FDA plans to name permanent center heads alongside FDA chief

Summary

The FDA is planning to announce senior personnel appointments including permanent heads of the Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER) when a new FDA commissioner is named.